Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay

Clinical Biochemistry

Volumn 45, Issue 10-11, 2012, Pages 711-713

  Apple, Fred S ^a   Smith, Stephen W ^a   Pearce, Lesly A ^b   Murakami, MaryAnn M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Biostatistical Consulting   (United States)

Author keywords

Acute coronary syndrome; Acute myocardial infarction; Biomarkers; Cardiac troponin; Delta changes; Risk stratification

Indexed keywords

TROPONIN I;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR MORTALITY; DIAGNOSTIC ACCURACY; FOLLOW UP; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOASSAY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS; TROPONIN I; YOUNG ADULT;

EID: 84862580045     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.02.030     Document Type: Article

References (14)

1. Apple FS, Collinson PO, for the IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays Clin Chem. 2011: published September 30, 2011 as doi:10.1373.
2. Apple F.S. Opinion: a new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009, 55:1303-1306.
3. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 2009, 30:162-169.
4. Reichlin T., Irfan A., Twerenbold R., et al. Utility of absolute and relative changes in cardiac troponin concentrations in early diagnosis of acute myocardial infarction. Circulation 2011, 124:136-145.
5. deFillipi C, de Lemos J, Christenson R, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010;304:2494-2502.
6. Apple F.S., Pearce L.A., Smith S.W., et al. Use of VITROS troponin I ES assay for early diagnosis of myocardial infarction and predicting of adverse events: role of following deltas. Clin Chem 2009, 55:930-938.
7. MacRae A.R., Kavsak P.A., Lustig V., et al. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies. Clin Chem 2006, 52:812-818.
8. Thygesen K., Alpert J.S., White H.D. Universal definition of myocardial infarction. J Am Coll Cardiol 2007, 50:2173-2195. on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the redefinition of Myocardial Infarction.
9. Morrow D.A., Cannon C.P., Jesse R.L., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007, 53:552-574.
10. Apple F.S., Smith S.W., Pearce L.A., et al. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2008, 54:723-728.
11. Fesmine F.M., Percy R.P., Bardoner J.B., et al. Serial creatine kinase (CK) MB testing during the emergency department evaluation of chest pain: utility of a 2-hour δ CK-MB of +1.6ng/ml. Am Heart J 1998, 136:237-244.
12. Fesmine F.M. Delta CK-MB outperforms delta troponin I at 2 hours during ED rule out of acute myocardial infarction. Am J Emerg Med 2000, 18:1-8.
13. Fesmire F.M., Fesmire C.E. Improved identification of acute coronary syndromes with second generation cardiac troponin I assay. Utility of 2-hour delta cTnI>+0.02ng/mL. J Emerg Med 2002, 22:147-152.
14. Reichlin T., Hochholzer W., Bassetti S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.